NCT03246828View on ClinicalTrials.gov

Glucagon in MODY (Maturity Onset Diabetes of the Young)

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 3, 2017

Primary Completion Date

July 29, 2022

Study Completion Date

August 1, 2022

Conditions
MODY1MODY3
Interventions
OTHER

Omission of gliclazide

Participants will stop taking gliclazide for 3 days. Data from the OGTT will be compared with that prior to stopping the medication.

Trial Locations (1)

OX3 7LE

Clinical Research Unit, OCDEM, Churchill Hospital, Oxford

All Listed Sponsors
collaborator

Oxford University Hospitals NHS Trust

OTHER

lead

University of Oxford

OTHER

NCT03246828 - Glucagon in MODY (Maturity Onset Diabetes of the Young) | Biotech Hunter | Biotech Hunter